Genetic Diversity and Dispersal of DENGUE Virus among Three Main Island Groups of the Philippines during 2015-2017

Viruses. 2023 Apr 28;15(5):1079. doi: 10.3390/v15051079.

Abstract

Dengue has been one of the major public health concerns in the Philippines for more than a century. The annual dengue case burden has been increasing in recent years, exceeding 200,000 in 2015 and 2019. However, there is limited information on the molecular epidemiology of dengue in the Philippines. We, therefore, conducted a study to understand the genetic composition and dispersal of DENV in the Philippines from 2015 to 2017 under UNITEDengue. Our analyses included 377 envelope (E) gene sequences of all 4 serotypes obtained from infections in 3 main island groups (Luzon, Visayas, and Mindanao) of the Philippines. The findings showed that the overall diversity of DENV was generally low. DENV-1 was relatively more diverse than the other serotypes. Virus dispersal was evident among the three main island groups, but each island group demonstrated a distinct genotype composition. These observations suggested that the intensity of virus dispersal was not substantive enough to maintain a uniform heterogeneity among island groups so that each island group behaved as an independent epidemiological unit. The analyses suggested Luzon as one of the major sources of DENV emergence and CAR, Calabarzon, and CARAGA as important hubs of virus dispersal in the Philippines. Our findings highlight the importance of virus surveillance and molecular epidemiological analyses to gain deep insights into virus diversity, lineage dominance, and dispersal patterns that could assist in understanding the epidemiology and transmission risk of dengue in endemic regions.

Keywords: dengue virus; evolution; genetic diversity; molecular epidemiology; phylogeography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dengue Virus* / genetics
  • Dengue*
  • Genetic Variation
  • Genotype
  • Humans
  • Philippines / epidemiology
  • Phylogeny

Grants and funding

This research was partially funded by the Canada Global Partnership Program under the project titled “ASEAN-GPP Grant Phase 3–Laboratory Capacity Development for diagnostics of Emerging Dangerous Pathogens”, grant number 4015-12/ASEAN. This work was also supported by institutional funds from the national Environment Agency, Singapore, and the Department of Health, Ministry of Health, Philippines.